<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1">
<front>
<journal-meta>
<journal-id journal-id-type="pmc">CHD</journal-id>
<journal-id journal-id-type="nlm-ta">CHD</journal-id>
<journal-id journal-id-type="publisher-id">CHD</journal-id>
<journal-title-group>
<journal-title>Congenital Heart Disease</journal-title>
</journal-title-group>
<issn pub-type="epub">1747-0803</issn>
<issn pub-type="ppub">1747-079X</issn>
<publisher>
<publisher-name>Tech Science Press</publisher-name>
<publisher-loc>USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">22648</article-id>
<article-id pub-id-type="doi">10.32604/chd.2022.022648</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Evaluation of Biventricular Volume and Systolic Function in Children with Ventricular Septal Defect and Moderate to Severe Pulmonary Hypertension Using Real-Time Three-Dimensional Echocardiography</article-title>
</title-group>
<contrib-group>
<contrib id="author-1" contrib-type="author">
<name name-style="western"><surname>Zhou</surname><given-names>Huan</given-names></name>
<xref ref-type="aff" rid="aff-1">1</xref><xref ref-type="author-notes" rid="afn1">&#x0023;</xref>
</contrib>
<contrib id="author-2" contrib-type="author">
<name name-style="western"><surname>Kang</surname><given-names>Jin</given-names></name>
<xref ref-type="aff" rid="aff-2">2</xref><xref ref-type="author-notes" rid="afn1">&#x0023;</xref>
</contrib>
<contrib id="author-3" contrib-type="author" corresp="yes">
<name name-style="western"><surname>Gao</surname><given-names>Jun</given-names></name>
<xref ref-type="aff" rid="aff-2">2</xref><email>gaojun026@sina.com</email>
</contrib>
<contrib id="author-4" contrib-type="author">
<name name-style="western"><surname>Feng</surname><given-names>Xiaoyuan</given-names></name>
<xref ref-type="aff" rid="aff-1">1</xref>
</contrib>
<contrib id="author-5" contrib-type="author">
<name name-style="western"><surname>Zhou</surname><given-names>Li</given-names></name>
<xref ref-type="aff" rid="aff-2">2</xref>
</contrib>
<contrib id="author-6" contrib-type="author">
<name name-style="western"><surname>Xiao</surname><given-names>Xia</given-names></name>
<xref ref-type="aff" rid="aff-2">2</xref>
</contrib>
<contrib id="author-7" contrib-type="author">
<name name-style="western"><surname>Meng</surname><given-names>Zhengliang</given-names></name>
<xref ref-type="aff" rid="aff-2">2</xref>
</contrib>
<contrib id="author-8" contrib-type="author">
<name name-style="western"><surname>Guo</surname><given-names>Chengwen</given-names></name>
<xref ref-type="aff" rid="aff-2">2</xref>
</contrib>
<aff id="aff-1"><label>1</label><institution>Children&#x2019;s Heart Center, Wuhan Children&#x2019;s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science &#x0026; Technology</institution>, <addr-line>Wuhan</addr-line>, <country>China</country></aff>
<aff id="aff-2"><label>2</label><institution>Department of Ultrasound, Wuhan Children&#x2019;s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science &#x0026; Technology</institution>, <addr-line>Wuhan</addr-line>, <country>China</country></aff>
</contrib-group><author-notes><corresp id="cor1"><label>&#x002A;</label>Corresponding Author: Jun Gao. Email: <email>gaojun026@sina.com</email></corresp>
<fn id="afn1" fn-type="other">
<p><sup>&#x0023;</sup>These authors contributed equally</p>
</fn></author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2022-10-03"><day>03</day>
<month>10</month>
<year>2022</year></pub-date>
<volume>17</volume>
<issue>6</issue>
<fpage>697</fpage>
<lpage>707</lpage>
<history>
<date date-type="received"><day>18</day><month>3</month><year>2022</year></date>
<date date-type="accepted"><day>06</day><month>6</month><year>2022</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2022 Zhou et al.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhou et al.</copyright-holder>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="https://techscience.com/chd/v17n6/22648/TSP_CHD_22648.pdf"></self-uri>
<abstract>
<p><bold>Background:</bold> Real-time three-dimensional echocardiography (RT-3DE) could obtain ventricular volume and ejection fraction rapidly and non-invasively without relying on ventricular morphology. This study aims to use RT-3DE to evaluate the changes in biventricular volume and systolic function in children with ventricular septal defect (VSD) and moderate to severe pulmonary hypertension (PH) before surgery. <bold>Methods:</bold> In this study 18 children with VSD and moderate to severe PH (VSD &#x002B; PH Group) and 18 healthy children of the same age (Control Group) were recruited. Biventricular volume and systolic function were evaluated by RT-3DE. The measurements included: left and right ventricular volume indexed to body surface area (BSA), stroke volume (SV) indexed to BSA, and ejection fraction (EF). <bold>Results:</bold> The results showed left and right ventricular volume indexed to BSA and SV indexed to BSA were significantly increased in VSD &#x002B; PH Group (VSD &#x002B; PH Group <italic>vs.</italic> Control Group), LVEDV/BSA (ml/m<sup>2</sup>): 48.67 &#x00B1; 21.46 <italic>vs.</italic> 25.59 &#x00B1; 6.96, RVEDV/BSA (ml/m<sup>2</sup>): 55.98 &#x00B1; 15.35 <italic>vs.</italic> 27.69 &#x00B1; 4.37, LVSV/BSA (ml/m<sup>2</sup>): 24.08 &#x00B1; 9.30 <italic>vs.</italic> 15.14 &#x00B1; 4.29, RVSV/BSA (ml/m<sup>2</sup>): 26.02 &#x00B1; 8.87 <italic>vs.</italic> 14.11 &#x00B1; 2.89, (<italic>P</italic> &#x003C; 0.05). While for EF in VSD &#x002B; PH Group decreased (VSD &#x002B; PH Group <italic>vs.</italic> Control Group), LVEF: 50.93 &#x00B1; 7.50&#x0025; <italic>vs.</italic> 59.38 &#x00B1; 7.24&#x0025;, RVEF: 45.84 &#x00B1; 7.71&#x0025; <italic>vs.</italic> 51.05 &#x00B1; 6.90&#x0025; (<italic>P</italic> &#x003C; 0.05). <bold>Conclusion:</bold> In children with VSD and moderate to severe PH, increased biventricular volume and decreased systolic function were observed with RT-3DE, but biventricular systolic function remained within acceptable limits. The children in this study recovered well after surgery without serious perioperative complications, suggesting that biventricular systolic function may help facilitate the surgical decision-making process in children with VSD and moderate-to-severe PH.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Real-time three-dimensional echocardiography</kwd>
<kwd>ventricular septal defect</kwd>
<kwd>pulmonary hypertension</kwd>
<kwd>children</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<label>1</label>
<title>Introduction</title>
<p>Ventricular septal defect (VSD) is one of the most common cardiac congenital malformations, accounting for almost 40&#x0025; of all cardiac anomalies [<xref ref-type="bibr" rid="ref-1">1</xref>]. The main factors that determine the pathophysiological response of VSD are the size and direction of the shunt at the ventricular level and the degree of ventricular volume load. In patients with large VSD without pulmonary vascular disease, the increase in the volume load of the left atrium and left ventricle leads to dilatation of the left ventricle and eccentric left ventricular hypertrophy. The presence of related long-term pulmonary hypertension may eventually lead to right ventricular hypertrophy and dilation [<xref ref-type="bibr" rid="ref-2">2</xref>]. Therefore, in the large VSD, the ventricular morphology and pumping function will undergo greater changes.</p>
<p>In children with large VSD, the amount of left-to-right shunt at the ventricular level may initially be small due to high pulmonary vascular resistance in the early neonatal period. As the pulmonary vascular resistance decreases, the shunt flow from left to right increases. At the same time, the patient&#x2019;s symptoms become more and more obvious due to excessive pulmonary blood flow. Interventricular shunting rises and the patient becomes increasingly symptomatic due to excessive pulmonary blood flow [<xref ref-type="bibr" rid="ref-3">3</xref>]. Children with large VSD and pulmonary hypertension (PH) usually have difficulty in breathing during the first few weeks of life and cannot grow and develop normally. In this case, surgery is usually recommended within 3 months after birth [<xref ref-type="bibr" rid="ref-2">2</xref>]. PH increases the risk of perioperative complications in children, prolongs the length of stay in the intensive care unit (ICU) and increases long-term mortality [<xref ref-type="bibr" rid="ref-4">4</xref>]. However, the current literature on ventricular size and function in children with VSD and PH is limited.</p>
<p>Two-dimensional (2D) and M-mode echocardiography are very important in the assessment of ventricular function, which are mainly measured based on geometric assumptions. The size and morphology of the ventricle in children with VSD and PH change, which is technically challenging [<xref ref-type="bibr" rid="ref-5">5</xref>]. Real-time three-dimensional echocardiography (RT-3DE) can directly measure the volume of the heart cavity and calculate the ejection fraction without relying on the geometry of the ventricular cavity, which can assess cardiac function in real time, non-invasively, quickly, and accurately. Therefore, this study aims to use RT-3DE to evaluate the changes in biventricular volume and systolic function in children with VSD and moderate-to-severe PH before surgery.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Methods</title>
<p>This study was approved by the Ethics Committee of Wuhan Children&#x2019;s Hospital (Approval No. 2021R103-E01). Prospectively collect data from all participants for statistical analysis.</p>
<sec id="s2_1">
<label>2.1</label>
<title>Study Population</title>
<sec id="s2_1_1">
<label>2.1.1</label>
<title>First Group: Healthy Volunteers (Control Group)</title>
<p>Prospectively collected healthy volunteers of the same age, a total of 21 cases were collected. The healthy volunteers were confirmed by clinical history, physical examination, electrocardiogram, and echocardiography.</p>
</sec>
<sec id="s2_1_2">
<label>2.1.2</label>
<title>Second Group: Children with VSD and Moderate-to-Severe PH (VSD &#x002B; PH Group)</title>
<p>Prospective collection of children with VSD and moderate-to-severe PH, inclusion criteria: 1) Simple VSD or VSD &#x002B; PFO (patent foramen ovale) (the shunt width of PFO &#x2264; 5mm); 2) The defect diameter of the ventricular septum &#x2265;2/3 of the inner diameter of the aortic valve annulus; 3) Systolic pulmonary arterial pressure (SPAP) &#x003D; right atrial pressure (approximately 5mmHg) &#x002B; pressure gradient inferred from peak tricuspid regurgitation velocity. Mean pulmonary arterial pressure (mPAP) &#x003D; right atrial pressure (approximately 5mmHg) &#x002B; pressure gradient inferred from peak pulmonary regurgitation velocity in early diastole. SPAP &#x2265; 50mmHg and/or mPAP &#x2265; 40mmHg were diagnostic criteria to be moderate to severe PH. Exclusion criteria: 1) VSD accompanied by other cardiac structural malformations; 2) VSD with cardiomyopathy. A total of 23 children were collected.</p>
<p>All the selected children with VSD and moderate-to-severe PH underwent an echocardiography examination one day before surgery, and the relevant conventional and 3-dimensional ultrasound images were collected; postoperative echocardiography at the bedside was performed within 1&#x2013;3 days after surgery to collect relevant conventional ultrasound image.</p>
</sec>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Echocardiography</title>
<p>All echocardiograms were acquired by a single experienced cardiac sonographer. The study was conducted while the children were sleeping or quiet.</p>
<p>All preoperative echocardiographic studies were performed using the commercially available IE33 system (Philips Medical Systems, Andover, MA). Matrixarray transducers (S5-1 and S8-3) were used to obtain the routine M-mode, 2-dimensional and Doppler related parameters, and a dedicated 3-dimensional full sampling transducer (X3-1) was used for the 3-dimensional full volume data sets acquisition. Using the X3-1 probe for inspection to obtain a clear apical four-chamber image by adjusting the image depth, gain, etc., and ensure that the sampling sector covers the entire area of interest. Then, we activated the 3D full volume imaging mode and obtained 3-dimensional full-volume ultrasound images of consecutive complete cardiac cycles of at least four cycles for image storage. The acquired images were then stored in DICOM format and imported into a TomTec software (Image-Arena 4.6) (TomTec Imaging Systems, Munich, Germany) for off-line analysis.</p>
<p>All postoperative echocardiograms were performed at the bedside using a commercially available M9 system (Mindray Healthcare system, Shenzhen, China). Matrixarray transducers P10-4s were used to obtain conventional M-mode, 2-dimensional and Doppler related parameters.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>RT-3DE Echocardiography Analysis</title>
<p>TomTec workstation LV-analysis and RV-Function software were used to analyze the left or right ventricular 3D volume database off-line respectively. LV-analysis: three standard sections of left ventricle including left ventricular apical four-chamber view, two-chamber view and three-chamber view were obtained by cutting and rotating the LV 3D database. The end-systolic and end-diastolic endocardial contours of left ventricle were delineated on the above three views (<xref ref-type="fig" rid="fig-1">Figs. 1A</xref> and <xref ref-type="fig" rid="fig-1">1B</xref>). RV-Function: three orthogonal sections of right ventricle including right ventricular four-chamber view, short axis view, coronal view was obtained by cutting and rotating the RV 3D database. Firstly, on the four-chamber view determined the central point of mitral annulus, tricuspid annulus, and the apical level of the left ventricular cavity. Secondly the end-systolic and the end-diastolic endocardial contours of the above three sections of the right ventricle were delineated. Chordae tendineae, papillary muscles, and regulatory bundles were included in the delineation (<xref ref-type="fig" rid="fig-1">Figs. 1C</xref> and <xref ref-type="fig" rid="fig-1">1D</xref>). Endocardial contours could be manually adjusted when necessary to optimize boundary position and tracking values were automatically calculated by the software. The left or right ventricular volume model were automatically generated by software and the volume-time curve was displayed by 2-dimensional coordinate diagram. Left and right ventricular end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), ejection fraction (EF) values were also given.</p>
<fig id="fig-1">
<label>Figure 1</label>
<caption>
<title>RT-3DE database analysis by TomTec</title></caption>
<graphic mimetype="image" mime-subtype="png" xlink:href="CHD_22648-fig-1.png"/>
</fig>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>LV-Analysis and RV-Function Reproducibility</title>
<p>Twelve subjects were randomly selected from the study subjects to estimate the variability of the TomTec LV-analysis and RV-Function software. The 3-dimensional echocardiography measurements were performed by the two experienced cardiac sonographers successively to calculate the inter-observer variability, each blind to the other&#x2019;s measurements. The other observer made a second measurement two weeks later to calculate the intra-observer variability. The reproducibility was estimated by the mean coefficient of variance (CV): the absolute value of the difference between the two measurements/the average value of the two measurements &#x00D7; 100&#x0025;.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Statistical Analysis</title>
<p>Statistical analyses were conducted using SPSS version 21.0 (IBM Corporation, Armonk, NY, USA). All collected data were verified for completeness and were tested using the Kolmogorov-Smirnov test for normality. Continuous variables were presented as the mean &#x00B1; standard deviation (SD) or median (interquartile range), and categorical variables were expressed as percentages. Continuous variables were compared using the independent sample t-test or Mann-Whitney U test, where appropriate. Chi-square test was used for the comparison of categorical variables. The Bland-Altman curve was used to test the inter- and intra-observer reproducibility of RT-3DE data. A <italic>P</italic> value&#x2009;&#x003C;&#x2009;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Clinical Characteristics</title>
<p>Among the initially enrolled 44 subjects (23 VSD &#x002B; moderate-to-severe PH patients, 21 controls). 5 VSD &#x002B; moderate-to-severe PH patients and 3 controls were excluded due to insufficient RT-3DE imaging quality. 18 VSD &#x002B; moderate-to-severe PH patients (12 females and 6 males), and 18 controls (10 females and 8 males) were included in the final analysis. Clinical characteristics of 18 VSD &#x002B; moderate-to-severe PH patients and 18 controls are presented in <xref ref-type="table" rid="table-1">Table 1</xref>. No significant difference was found between the groups in terms of clinical characteristics including age, sex, height, and heart rate (all <italic>P</italic> &#x003E; 0.05). In contrast, the weight and body surface area (BSA) were significantly lower in VSD &#x002B; PH Group as compared to Control Group (<xref ref-type="fig" rid="fig-2">Fig. 2</xref>) (<italic>P</italic> &#x003C; 0.05).</p>
<table-wrap id="table-1"><label>Table 1</label>
<caption>
<title>Clinical characteristics</title></caption>
<table><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Parameters</th>
<th align="left">Control Group (n&#x2009;&#x003D;&#x2009;18)</th>
<th align="left">VSD &#x002B; PH Group (n&#x2009;&#x003D;&#x2009;18)</th>
<th align="left"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Age, months (minimum, median, maximum)</td>
<td align="left">2, 6.50, 33</td>
<td align="left">2, 5.50, 33</td>
<td align="left">0.542</td>
</tr>
<tr>
<td align="left">Male, n (&#x0025;)</td>
<td align="left">8(44)</td>
<td align="left">6(33)</td>
<td align="left">0.637</td>
</tr>
<tr>
<td align="left">Height, cm (mean &#x00B1; SD)</td>
<td align="left">68.61&#x2009;&#x00B1;&#x2009;7.86</td>
<td align="left">66.47&#x2009;&#x00B1;&#x2009;8.29</td>
<td align="left">0.439</td>
</tr>
<tr>
<td align="left">Weight, kg (mean &#x00B1; SD)</td>
<td align="left">8.39&#x2009;&#x00B1;&#x2009;1.90</td>
<td align="left">6.64&#x2009;&#x00B1;&#x2009;1.96</td>
<td align="left">0.011</td>
</tr>
<tr>
<td align="left">BSA, body surface area, m<sup>2</sup> (mean &#x00B1; SD)</td>
<td align="left">0.38&#x2009;&#x00B1;&#x2009;0.07</td>
<td align="left">0.33&#x2009;&#x00B1;&#x2009;0.07</td>
<td align="left">0.048</td>
</tr>
<tr>
<td align="left">Heart rate, bpm (mean &#x00B1; SD)</td>
<td align="left">126.78&#x2009;&#x00B1;&#x2009;19.67</td>
<td align="left">126.56&#x2009;&#x00B1;&#x2009;14.90</td>
<td align="left">0.970</td>
</tr>
</tbody>
</table>
</table-wrap><fig id="fig-2">
<label>Figure 2</label>
<caption>
<title>Comparison of weight and BSA of the normal group and the VSD &#x002B; PH group. Asterisks indicate significant differences (<italic>P</italic> &#x003C;&#x2009;0.05)</title></caption>
<graphic mimetype="image" mime-subtype="png" xlink:href="CHD_22648-fig-2.png"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Echocardiographic Characteristics</title>
<p>The echocardiographic parameters were summarized in <xref ref-type="table" rid="table-2">Table 2</xref>. The ventricular septal defects in VSD &#x002B; PH Group were medium to large. The proportion of children with bidirectional ventricular shunt was 83.33&#x0025; (15/18 cases) in the study. SPAP &#x2265; 50mmHg and/or mPAP &#x2265; 40mmHg can be estimated from <xref ref-type="fig" rid="fig-3">Fig. 3A</xref>. Compared with Control Group, the volume of left and right ventricle in VSD &#x002B; PH Group were significantly higher (VSD &#x002B; PH Group <italic>vs.</italic> Control Group), LVEDV/BSA: 48.67 &#x00B1; 21.46ml/m<sup>2</sup> <italic>vs.</italic> 25.59 &#x00B1; 6.96ml/m<sup>2</sup>, RVEDV/BSA: 55.98 &#x00B1; 15.35ml/m<sup>2</sup> <italic>vs.</italic> 27.69 &#x00B1; 4.37ml/m<sup>2</sup> (<xref ref-type="fig" rid="fig-3">Fig. 3B</xref>), while systolic function indexes: LVEF and RVEF decreased slightly (VSD &#x002B; PH Group <italic>vs.</italic> Control Group), LVEF: 50.93 &#x00B1; 7.50&#x0025; <italic>vs.</italic> 59.38 &#x00B1; 7.24&#x0025;, RVEF: 45.84&#x2009;&#x00B1;&#x2009;7.71&#x0025; <italic>vs.</italic> 51.05 &#x00B1; 6.90&#x0025; (<xref ref-type="fig" rid="fig-3">Fig. 3C</xref>). At the same time biventricular stroke volume indexed to BSA (LVSV/BSA, RVSV/BSA) in VSD &#x002B; PH Group increased significantly (VSD &#x002B; PH Group <italic>vs.</italic> Control Group), LVSV/BSA: 24.08 &#x00B1; 9.30 ml/m<sup>2</sup> <italic>vs.</italic> 15.14 &#x00B1; 4.29 ml/m<sup>2</sup>, RVSV/BSA: 26.02 &#x00B1; 8.87 ml/m<sup>2</sup> <italic>vs.</italic> 14.11&#x2009;&#x00B1;&#x2009;2.89 ml/m<sup>2</sup> (<xref ref-type="fig" rid="fig-3">Fig. 3D</xref>) (<italic>P</italic> &#x003C;&#x2009;0.05).</p>
<table-wrap id="table-2"><label>Table 2</label>
<caption>
<title>Echocardiographic characteristics</title></caption>
<table><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Parameters</th>
<th align="left">Control Group (n&#x2009;&#x003D;&#x2009;18)</th>
<th align="left">VSD &#x002B; PH Group (n&#x2009;&#x003D;&#x2009;18)</th>
<th align="left"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">VSD diameter (mm)</td>
<td align="left">-</td>
<td align="left">10.35&#x2009;&#x00B1;&#x2009;2.55</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">PA/AO ratio</td>
<td align="left">0.90&#x2009;&#x00B1;&#x2009;0.09</td>
<td align="left">1.44&#x2009;&#x00B1;&#x2009;0.25</td>
<td align="left">0.000</td>
</tr>
<tr>
<td align="left">Bi-directional shunt (&#x0025;)</td>
<td align="left">-</td>
<td align="left">15(83.33)</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">TR (mmHg)</td>
<td align="left">21.19&#x2009;&#x00B1;&#x2009;3.56</td>
<td align="left">75.89&#x2009;&#x00B1;&#x2009;21.16</td>
<td align="left">0.000</td>
</tr>
<tr>
<td align="left">TR-POST.OP (mmHg)</td>
<td align="left">-</td>
<td align="left">17.09&#x2009;&#x00B1;&#x2009;8.71</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">PR (mmHg)</td>
<td align="left">10.33&#x2009;&#x00B1;&#x2009;2.64</td>
<td align="left">49.17&#x2009;&#x00B1;&#x2009;21.48</td>
<td align="left">0.000</td>
</tr>
<tr>
<td align="left">PR-POST.OP (mmHg)</td>
<td align="left">-</td>
<td align="left">12.36&#x2009;&#x00B1;&#x2009;9.87</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">LVD (mm)</td>
<td align="left">22.82&#x2009;&#x00B1;&#x2009;2.33</td>
<td align="left">25.90&#x2009;&#x00B1;&#x2009;5.46</td>
<td align="left">0.044</td>
</tr>
<tr>
<td align="left">RVD (mm)</td>
<td align="left">15.13&#x2009;&#x00B1;&#x2009;2.11</td>
<td align="left">17.34&#x2009;&#x00B1;&#x2009;3.11</td>
<td align="left">0.049</td>
</tr>
<tr>
<td align="left">LVEDV/BSA (ml/m<sup>2</sup>)</td>
<td align="left">25.59&#x2009;&#x00B1;&#x2009;6.96</td>
<td align="left">48.67&#x2009;&#x00B1;&#x2009;21.46</td>
<td align="left">0.000</td>
</tr>
<tr>
<td align="left">RVEDV/BSA (ml/m<sup>2</sup>)</td>
<td align="left">27.69&#x2009;&#x00B1;&#x2009;4.37</td>
<td align="left">55.98&#x2009;&#x00B1;&#x2009;15.35</td>
<td align="left">0.000</td>
</tr>
<tr>
<td align="left">LVSV/BSA (ml/m<sup>2</sup>)</td>
<td align="left">15.14&#x2009;&#x00B1;&#x2009;4.29</td>
<td align="left">24.08&#x2009;&#x00B1;&#x2009;9.30</td>
<td align="left">0.002</td>
</tr>
<tr>
<td align="left">RVSV/BSA (ml/m<sup>2</sup>)</td>
<td align="left">14.11&#x2009;&#x00B1;&#x2009;2.89</td>
<td align="left">26.02&#x2009;&#x00B1;&#x2009;8.87</td>
<td align="left">0.000</td>
</tr>
<tr>
<td align="left">LVEF (RT-3DE) (&#x0025;)</td>
<td align="left">59.38&#x2009;&#x00B1;&#x2009;7.24</td>
<td align="left">50.93&#x2009;&#x00B1;&#x2009;7.50</td>
<td align="left">0.002</td>
</tr>
<tr>
<td align="left">RVEF (RT-3DE) (&#x0025;)</td>
<td align="left">51.05&#x2009;&#x00B1;&#x2009;6.90</td>
<td align="left">45.84&#x2009;&#x00B1;&#x2009;7.71</td>
<td align="left">0.040</td>
</tr>
</tbody>
</table>
<table-wrap-foot><fn>
<p>Note: In each box of the measurements, the mean value&#x2009;&#x00B1;&#x2009;standard deviation is described in the upper box.</p>
</fn><fn>
<p>PA/AO ratio: ratio of pulmonary trunk diameter to ascending aorta diameter;</p>
</fn><fn>
<p>TR/PR: the peak tricuspid regurgitation gradient and the early diastolic gradient of pulmonary regurgitation;</p>
</fn><fn>
<p>TR/PR-POST.OP: the peak tricuspid regurgitation gradient and the early diastolic gradient of pulmonary regurgitation post operation;</p>
</fn><fn>
<p>LVD: left ventricle antero-posterior diameter;</p>
</fn><fn>
<p>RVD: right ventricle transverse diameter;</p>
</fn><fn>
<p>LVEDV/BSA and RVEDV/BSA: left/right ventricular end-diastolic volume indexed to BSA obtained by RT-3DE;</p>
</fn><fn>
<p>LVSV/BSA and RVSV/BSA: left/right ventricular stoke volume indexed to BSA obtained by RT-3DE;</p>
</fn><fn>
<p>LVEF/RVEF (RT-3DE): left/right ventricular ejection fraction obtained by RT-3DE.</p>
</fn>
</table-wrap-foot>
</table-wrap><fig id="fig-3">
<label>Figure 3</label>
<caption>
<title>Comparison of some ultrasound data. Asterisks indicate significant differences (<italic>P</italic> &#x003C;&#x2009;0.05)</title></caption>
<graphic mimetype="image" mime-subtype="png" xlink:href="CHD_22648-fig-3.png"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Reproducibility</title>
<p>The Bland-Altman diagram shows a high degree of agreement within and between observers, with good repeatability (<xref ref-type="fig" rid="fig-4">Figs. 4</xref> and <xref ref-type="fig" rid="fig-5">5</xref>).</p>
<fig id="fig-4">
<label>Figure 4</label>
<caption>
<title>BA curve for intra-observer variability of LVEDV(A), LVEF(B), RVEDV(C), RVEF(D)</title></caption>
<graphic mimetype="image" mime-subtype="png" xlink:href="CHD_22648-fig-4.png"/>
</fig><fig id="fig-5">
<label>Figure 5</label>
<caption>
<title>BA curve for inter-observer variability of LVEDV(A), LVEF(B), RVEDV(C), RVEF(D)</title></caption>
<graphic mimetype="image" mime-subtype="png" xlink:href="CHD_22648-fig-5.png"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Clinical and Surgical Outcome</title>
<p>All 18 children of VSD &#x002B; PH Group had rough breathing sounds in both lungs, wet rales were heard in 6 cases. Chest X-ray film showed 18 cases pulmonary congestion, 12 cases bronchiolitis pneumonia, and 3 cases lung consolidation. Although children in the VSD &#x002B; PH Group had clinical symptoms of pulmonary congestion and cardiac insufficiency before surgery, all children recovered well after surgery.</p>
<p>Postoperative bedside echocardiography showed that the peak tricuspid regurgitation gradient and the early diastolic gradient of pulmonary regurgitation were significantly lower than those before surgery, which were 17.09&#x2009;&#x00B1;&#x2009;8.71mmHg and 12.36&#x2009;&#x00B1;&#x2009;9.87mmHg, respectively (<xref ref-type="table" rid="table-2">Table 2</xref> and <xref ref-type="fig" rid="fig-3">Fig. 3A</xref>). The postoperative mechanical ventilation time of 18 children was 1&#x2013;8 days, with an average of 3.56 &#x00B1; 2.15 days, and the discharge time was 6&#x2013;15 days, with an average of 10.17 &#x00B1; 2.83 days.</p>

</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>Discussion</title>
<p>Patients with cardiac defects which result in left-to-right shunting are at risk of developing PH, owing to the increased shear stress and circumferential stretch induced by increased pulmonary blood flow, which leads to endothelial dysfunction and progressive vascular remodeling and, thus, increased pulmonary vascular resistance [<xref ref-type="bibr" rid="ref-6">6</xref>]. For large VSD, there is a large left-to-right shunt at the ventricular level, leading to early increased pulmonary artery pressure, often with repeated pneumonia, congestive heart failure and growth retardation, and even life-threatening [<xref ref-type="bibr" rid="ref-7">7</xref>,<xref ref-type="bibr" rid="ref-8">8</xref>]. In this study, the growth and development of children in the VSD &#x002B; PH Group had lower body weight and BSA than the Control Group (<xref ref-type="fig" rid="fig-2">Fig. 2</xref>), and all had severe lung infections.</p>

<p>More and more reports indicate that early surgery is very effective in improving the prognosis of VSD combined with PH [<xref ref-type="bibr" rid="ref-2">2</xref>]. Early surgery can block the shunt and reduce the pulmonary blood flow, which is an effective means to prevent the transition from dynamic pulmonary hypertension to resistance pulmonary hypertension. Research by Rabinovitch et al. [<xref ref-type="bibr" rid="ref-9">9</xref>] showed that in 215 cases of congenital heart disease with PH, the average pulmonary artery pressure and/or pulmonary vascular resistance dropped to normal at 9 months after surgery, which was not related to the severity of intraoperative pulmonary vascular disease. Due to the immaturity of myocardial structure, function and metabolism, infants usually have poor tolerance to surgical trauma and ischemia. PH will also increase the risk of perioperative complications, prolong the length of ICU stay and increase long-term mortality [<xref ref-type="bibr" rid="ref-4">4</xref>]. Low cardiac output syndrome (LCOS) is one of the most serious complications of cardiac surgery. Preoperative assessment of cardiac function and selection of appropriate operation time are beneficial to reduce the occurrence of postoperative LCOS and arrhythmia [<xref ref-type="bibr" rid="ref-10">10</xref>&#x2013;<xref ref-type="bibr" rid="ref-12">12</xref>]. Therefore, the timing of intervention in patients with VSD and PH is important, but it is often difficult to determine the optimal timing because of the lack of reliable data to guide decision-making.</p>
<p>Because of the morphological changes of the ventricle in children with VSD and moderate to severe PH, it is difficult to assume a single geometric shape. Conventional 2D echocardiography is difficult to measure ventricular systolic function, and 3D echocardiography addresses this problem. Previous studies have shown that RT-3DE has good correlation and consistency with angiography, MRI, and radionuclide ventricular angiography in the assessment of ventricular volume and EF [<xref ref-type="bibr" rid="ref-13">13</xref>,<xref ref-type="bibr" rid="ref-14">14</xref>]. Our study confirmed the feasibility of using RT-3DE to assess the bilateral ventricular volume and ejection fraction of children with VSD and moderate-to-severe PH. Our results showed that the left and right ventricular volume and stroke volume of children with VSD and moderate-to-severe PH increased, indicating that the bilateral ventricles were overloaded, and the ventricular pumping function was compensatory enhanced, the bilateral ventricles cannot fully pump the increased blood volume into the systemic and pulmonary circulation. RT-3DE showed that the ventricular systolic function of the VSD &#x002B; PH Group before operation was lower than that of the Control Group, and the ventricle was enlarged. LVEF &#x2265;&#x2009;50&#x0025; is considered to have preserved ejection fraction [<xref ref-type="bibr" rid="ref-15">15</xref>], and the normal reference value of RVEF is 44&#x0025; [<xref ref-type="bibr" rid="ref-16">16</xref>]. In our study, left ventricular systolic function (LVEF50.93&#x2009;&#x00B1;&#x2009;7.50&#x0025;) and right ventricular systolic function (RVEF45.84&#x2009;&#x00B1;&#x2009;7.71&#x0025;) in children with VSD &#x002B; PH were still within an acceptable range. Recent studies have shown that RV volume and EF detected by RT-3DE are independent predictors of intermediate-high risk stratification in patients with PH [<xref ref-type="bibr" rid="ref-17">17</xref>], as well as independent predictors of prognosis [<xref ref-type="bibr" rid="ref-18">18</xref>]. An underfilling of the left heart rather than an intrinsic LV dysfunction is the mechanism behind the reduced longitudinal function [<xref ref-type="bibr" rid="ref-19">19</xref>]. Accurate assessment of biventricular systolic function may help to facilitate the decision-making process for surgery in children with VSD and moderate-to-severe PH. Considering that no patients with surgical failure or serious postoperative complications were included in the study, it is impossible to judge that the biventricular systolic function is the key to the timing of surgery.</p>
<p>Several limitations should be considered in interpreting the results of this investigation. First, a major limitation of our study was that the numbers were small, and the follow-up period was short. Thus, further study involving the large number of patients will be needed. Second, it is worth noting that several subjects failed to apply for LV-function and RV-Function software analysis successfully. The reason was that the real-time 3D volume database may be misaligned between images due to the limited frame frequency and the fast heart rate of infants. Finally, confined by RT-3DE image resolution, indistinct endocardial boundaries could also lead to overestimation or underestimation of true values when delineating endocardium.</p>
</sec>
<sec id="s5">
<label>5</label>
<title>Conclusion</title>
<p>In this study, we observed infants with VSD and moderate-to-severe PH with growth retardation and severe pulmonary infection, increased bilateral ventricular volume, stroke volume, and decreased EF, but the biventricular systolic function is still within an acceptable range. The children in this study recovered well after surgery without serious perioperative complications, suggesting that biventricular systolic function measured by RT-3DE may help facilitate the surgical decision-making process in children with VSD and moderate-to-severe PH. Further large-scale prospective studies are needed to determine the general significance of these findings.</p>
</sec>
</body>
<back>
<ack>
<p>Thanks to Professor Mingxing Xie of Tongji Medical College of Huazhong University of Science and Technology for his guidance and suggestions in this study.</p>
</ack><fn-group>
<fn fn-type="other">
<p><bold>Authorship:</bold> The authors confirm contribution to the paper as follows: study conception and design: Huan Zhou and Jun Gao; data collection: Jin Kang, Xiaoyuan Feng, Li Zhou, Xia Xiao, Zhengliang Meng and Chengwen Guo; analysis and interpretation of results: Huan Zhou, Jin Kang and Jun Gao; draft manuscript preparation: Huan Zhou and Jun Gao. All authors reviewed the results and approved the final version of the manuscript.</p>
</fn>
<fn fn-type="other">
<p><bold>Ethics Statement:</bold> This study was approved by the ethics committee of our hospital. Prospectively collect data from all participants for statistical analysis.</p>
</fn>
<fn fn-type="other">
<p><bold>Funding Statement:</bold> Wuhan Health and Family Planning Commission Grant/Award (WX16D18).</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflicts of Interest:</bold> The authors declare that they have no conflicts of interest to report regarding the present study.</p>
</fn>
</fn-group>
<ref-list content-type="authoryear">
<title>References</title>
<ref id="ref-1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoffman</surname>, <given-names>J. I.</given-names></string-name></person-group> (<year>1995</year>). <article-title>Incidence of congenital heart disease: I. Postnatal incidence</article-title>. <source>Pediatric Cardiology</source><italic>,</italic> <volume>16</volume>
<issue>(3)</issue><italic>,</italic> <fpage>103</fpage>&#x2013;<lpage>113</lpage>. DOI <pub-id pub-id-type="doi">10.1007/BF00801907</pub-id>.</mixed-citation></ref>
<ref id="ref-2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Penny</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Vick III</surname>, <given-names>G. W.</given-names></string-name></person-group> (<year>2011</year>). <article-title>Ventricular septal defect</article-title>. <source>Lancet</source><italic>,</italic> <volume>377</volume>
<issue>(9771)</issue><italic>,</italic> <fpage>1103</fpage>&#x2013;<lpage>1112</lpage>. DOI <pub-id>10.1016/S0140-6736(10)61339-6</pub-id>.</mixed-citation></ref>
<ref id="ref-3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rudolph</surname>, <given-names>A. M.</given-names></string-name></person-group> (<year>1971</year>). <article-title>Circulatory adjustments after birth: Effects on ventricular septal defect</article-title>. <source>British Heart Journal</source><italic>,</italic> <volume>33</volume><italic>,</italic> <fpage>32</fpage>&#x2013;<lpage>34</lpage>. DOI <pub-id pub-id-type="doi">10.1136/hrt.33.Suppl.32</pub-id>.</mixed-citation></ref>
<ref id="ref-4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barber</surname>, <given-names>R. L.</given-names></string-name>, <string-name><surname>Fletcher</surname>, <given-names>S. N.</given-names></string-name></person-group> (<year>2014</year>). <article-title>A review of echocardiography in anaesthetic and peri-operative practice. Part 1: Impact and utility</article-title>. <source>Anaesthesia</source><italic>,</italic> <volume>69</volume>
<issue>(7)</issue><italic>,</italic> <fpage>764</fpage>&#x2013;<lpage>776</lpage>. DOI <pub-id pub-id-type="doi">10.1111/anae.12663</pub-id>.</mixed-citation></ref>
<ref id="ref-5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xing</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kong</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal></person-group> (<year>2019</year>). <article-title>Evaluation of left atrial volume and function in patients with coronary slow flow phenomenon using real-time three-dimensional echocardiography</article-title>. <source>The International Journal of Cardiovascular Imaging</source><italic>,</italic> <volume>35</volume>
<issue>(12)</issue><italic>,</italic> <fpage>2197</fpage>&#x2013;<lpage>2203</lpage>. DOI <pub-id pub-id-type="doi">10.1007/s10554-019-01676-9</pub-id>.</mixed-citation></ref>
<ref id="ref-6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gatzoulis</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Alonso-Gonzalez</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Beghetti</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2009</year>). <article-title>Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease</article-title>. <source>European Respiratory Review</source><italic>,</italic> <volume>18</volume>
<issue>(113)</issue><italic>,</italic> <fpage>154</fpage>&#x2013;<lpage>161</lpage>. DOI <pub-id pub-id-type="doi">10.1183/09059180.00003309</pub-id>.</mixed-citation></ref>
<ref id="ref-7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Castaneda</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Mayer Jr</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Jonas</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Lock</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Wessel</surname>, <given-names>D. L.</given-names></string-name> <etal>et al.</etal></person-group> (<year>1989</year>). <article-title>The neonate with critical congenital heart disease: Repair--a surgical challenge</article-title>. <source>The Journal of Thoracic and Cardiovascular Surgery</source><italic>,</italic> <volume>98</volume>
<issue>(5)</issue><italic>,</italic> <fpage>869</fpage>&#x2013;<lpage>875</lpage>. DOI <pub-id pub-id-type="doi">10.1016/S0022-5223(19)34265-5</pub-id>.</mixed-citation></ref>
<ref id="ref-8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhatt</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Roth</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Kumar</surname>, <given-names>R. K.</given-names></string-name>, <string-name><surname>Gauvreau</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Nair</surname>, <given-names>S. G.</given-names></string-name> <etal>et al.</etal></person-group> (<year>2004</year>). <article-title>Management of infants with large, unrepaired ventricular septal defects and respiratory infection requiring mechanical ventilation</article-title>. <source>The Journal of Thoracic and Cardiovascular Surgery</source><italic>,</italic> <volume>127</volume>
<issue>(5)</issue><italic>,</italic> <fpage>1466</fpage>&#x2013;<lpage>1473</lpage>. DOI <pub-id pub-id-type="doi">10.1016/j.jtcvs.2003.11.030</pub-id>.</mixed-citation></ref>
<ref id="ref-9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rabinovitch</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Keane</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Norwood</surname>, <given-names>W. I.</given-names></string-name>, <string-name><surname>Castaneda</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Reid</surname>, <given-names>L.</given-names></string-name></person-group> (<year>1984</year>). <article-title>Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects</article-title>. <source>Circulation</source><italic>,</italic> <volume>69</volume>
<issue>(4)</issue><italic>,</italic> <fpage>655</fpage>&#x2013;<lpage>667</lpage>. DOI <pub-id pub-id-type="doi">10.1161/01.CIR.69.4.655</pub-id>.</mixed-citation></ref>
<ref id="ref-10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chin</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>N. H.</given-names></string-name>, <string-name><surname>Rubin</surname>, <given-names>L. J.</given-names></string-name></person-group> (<year>2005</year>). <article-title>The right ventricle in pulmonary hypertension</article-title>. <source>Coronary Artery Disease</source><italic>,</italic> <volume>16</volume>
<issue>(1)</issue><italic>,</italic> <fpage>13</fpage>&#x2013;<lpage>18</lpage>. DOI <pub-id pub-id-type="doi">10.1097/00019501-200502000-00003</pub-id>.</mixed-citation></ref>
<ref id="ref-11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Humbert</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2007</year>). <article-title>The burden of pulmonary hypertension</article-title>. <source>The European Respiratory Journal</source><italic>,</italic> <volume>30</volume>
<issue>(1)</issue><italic>,</italic> <fpage>1</fpage>&#x2013;<lpage>2</lpage>. DOI <pub-id>10.1183/09031936.00055407</pub-id>.</mixed-citation></ref>
<ref id="ref-12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van Wolferen</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>van de Veerdonk</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Mauritz</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Jacobs</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Marcus</surname>, <given-names>J. T.</given-names></string-name> <etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Clinically significant change in stroke volume in pulmonary hypertension</article-title>. <source>Chest</source><italic>,</italic> <volume>139</volume>
<issue>(5)</issue><italic>,</italic> <fpage>1003</fpage>&#x2013;<lpage>1009</lpage>. DOI <pub-id>10.1378/chest.10-1066</pub-id>.</mixed-citation></ref>
<ref id="ref-13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Niemann</surname>, <given-names>P. S.</given-names></string-name>, <string-name><surname>Pinho</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Balbach</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Galuschky</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Blankenhagen</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal></person-group> (<year>2007</year>). <article-title>Anatomically oriented right ventricular volume measurements with dynamic three-dimensional echocardiography validated by 3-tesla magnetic resonance imaging</article-title>. <source>Journal of the American College of Cardiology</source><italic>,</italic> <volume>50</volume>
<issue>(17)</issue><italic>,</italic> <fpage>1668</fpage>&#x2013;<lpage>1676</lpage>. DOI <pub-id>10.1016/j.jacc.2007.07.031</pub-id>.</mixed-citation></ref>
<ref id="ref-14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnson</surname>, <given-names>T. R.</given-names></string-name>, <string-name><surname>Hoch</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Huber</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>R&#x00F6;mer</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Reiser</surname>, <given-names>M. F.</given-names></string-name> <etal>et al.</etal></person-group> (<year>2006</year>). <article-title>Quantifizierung der rechtsventrikul&#x00E4;ren funktion bei angeborenen herzfehlern: Korrelation von 3D-echokardiographie und MRT als sich erg&#x00E4;nzende methoden [Quantification of right ventricular function in congenital heart disease: Correlation of 3D echocardiography and MRI as complementary methods]</article-title>. <source>RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin</source><italic>,</italic> <volume>178</volume>
<issue>(10)</issue><italic>,</italic> <fpage>1014</fpage>&#x2013;<lpage>1021</lpage>. DOI <pub-id>10.1055/s-2006-926945</pub-id>.</mixed-citation></ref>
<ref id="ref-15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McDonagh</surname>, <given-names>T. A.</given-names></string-name>, <string-name><surname>Metra</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Adamo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gardner</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Baumbach</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal></person-group> (<year>2021</year>). <article-title>2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure</article-title>. <source>European Heart Journal</source><italic>,</italic> <volume>42</volume>
<issue>(36)</issue><italic>,</italic> <fpage>3599</fpage>&#x2013;<lpage>3726</lpage>. DOI <pub-id>10.1093/eurheartj/ehab368</pub-id>.</mixed-citation></ref>
<ref id="ref-16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ramani</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Patel</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Judy</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ton</surname>, <given-names>V. K.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Noninvasive assessment of right ventricular function in patients with pulmonary arterial hypertension and left ventricular assist device</article-title>. <source>Current Cardiology Reports</source><italic>,</italic> <volume>21</volume>
<issue>(8)</issue><italic>,</italic> <fpage>82</fpage>. DOI <pub-id>10.1007/s11886-019-1156-2</pub-id>.</mixed-citation></ref>
<ref id="ref-17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>B. Y.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>W. C.</given-names></string-name>, <string-name><surname>Zeng</surname>, <given-names>Q. X.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Z. H.</given-names></string-name>, <string-name><surname>Niu</surname>, <given-names>L. L.</given-names></string-name> <etal>et al.</etal></person-group> (<year>2020</year>). <article-title>The value of three-dimensional echocardiography in risk stratification in pulmonary arterial hypertension: A cross-sectional study</article-title>. <source>The International Journal of Cardiovascular Imaging</source><italic>,</italic> <volume>36</volume>
<issue>(4)</issue><italic>,</italic> <fpage>577</fpage>&#x2013;<lpage>584</lpage>. DOI <pub-id>10.1007/s10554-019-01743-1</pub-id>.</mixed-citation></ref>
<ref id="ref-18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moceri</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Duchateau</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Baudouy</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Schouver</surname>, <given-names>E. D.</given-names></string-name>, <string-name><surname>Leroy</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal></person-group> (<year>2018</year>). <article-title>Three-dimensional right-ventricular regional deformation and survival in pulmonary hypertension</article-title>. <source>European Heart Journal-Cardiovascular Imaging</source><italic>,</italic> <volume>19</volume>
<issue>(4)</issue><italic>,</italic> <fpage>450</fpage>&#x2013;<lpage>458</lpage>. DOI <pub-id>10.1093/ehjci/jex163</pub-id>.</mixed-citation></ref>
<ref id="ref-19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sj&#x00F6;gren</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kjellstr&#x00F6;m</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Bredfelt</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Steding-Ehrenborg</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>R&#x00E5;degran</surname>, <given-names>G.</given-names></string-name> <etal>et al.</etal></person-group> (<year>2021</year>). <article-title>Underfilling decreases left ventricular function in pulmonary arterial hypertension</article-title>. <source>The International Journal of Cardiovascular Imaging</source><italic>,</italic> <volume>37</volume>
<issue>(5)</issue><italic>,</italic> <fpage>1745</fpage>&#x2013;<lpage>1755</lpage>. DOI <pub-id>10.1007/s10554-020-02143-6</pub-id>.</mixed-citation></ref>
</ref-list>
</back>
</article>






